Diet pills and the cataract outbreak of 1935: Reflections on the evolution of consumer protection legislation
Abstract
An outbreak of cataracts in 1935 caused by dinitrophenol (DNP), the active ingredient of popular diet pills, highlighted the inability of the U.S. Food and Drug Administration (FDA) to prevent harmful drugs from entering the marketplace. Just two years earlier, the FDA used horrific images of ocular surface injury caused by cosmetics at the World's Fair in Chicago to garner public support for legislative reform. The FDA had to walk a fine line between a public awareness campaign and lobbying Congress while lawmakers debated the need for consumer protection. The cataract outbreak of 1935 was conspicuous in the medical literature during the height of New Deal legislation, but questions persist as to how much it affected passage of the proposed Food, Drug, and Cosmetic Act (of 1938). The legislation languished in committee for years. The cataract outbreak probably had little impact on the eventual outcome, but medical opinion concerning the safety of DNP may have contributed to the voluntary withdrawal of the diet drug from the market. We review the DNP cataract outbreak and examine it in context of the challenges facing regulatory reform at that time.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Reported side effects of DNP include acute cataract, sensory axonal polyneuropathy, fever, tachycardia, sweating, nausea, rash, breathing difficulties, abdominal pain, agitation, headache, and death.
“The reported side effects of DNP include acute cataract [261,262], sensory axonal polyneuropathy [263], fever, tachycardia, sweating, nausea, rash, breathing difficulties, abdominal pain, agitation, headache, and death [264,265].”
From Mitochondrial Uncoupling: A Key Controller of Biological Processes in Physiology and Diseases (2019) · cites this paper as [261]
Cites
REVERSIBLE INHIBITION OF THE COUPLING BETWEEN PHOSPHORYLATION AND OXIDATION
Loomis, W. F., & Lipmann, F. A. (1948) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)57455-x · Cited by 656 · see citing works
2,4-Dinitrophenol (DNP): A Weight Loss Agent with Significant Acute Toxicity and Risk of Death
Grundlingh, J., Dargan, P. I., El-Zanfaly, M., & Wood, D. M. (2011) · Journal of Medical Toxicology · doi:10.1007/s13181-011-0162-6 · Cited by 470 · see citing works
Elixirs, Diluents, and the Passage of the 1938 Federal Food, Drug and Cosmetic Act
Wax, P. M. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-6-199503150-00009 · Cited by 236 · see citing works
Protecting America's health: the FDA, business, and one hundred years of regulation
(2004) · Choice Reviews Online · doi:10.5860/choice.41-2838 · Cited by 174 · see citing works
Elixirs, Diluents, and the Passage the 1938 Federal Food, Drug and Cosmetic Act
&NA; (1996) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-199607000-00005 · Cited by 174 · see citing works
Dinitrophenol and obesity: an early twentieth-century regulatory dilemma
Colman, E. (2007) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2007.03.006 · Cited by 160 · see citing works
MECHANISMS OF DINITROPHENOL TOXICITY
SIMON, E. W. (1953) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/j.1469-185x.1953.tb01389.x · Cited by 151 · see citing works
Obesity treated with triiodothyronine and low calorie liquid diet.
Taylor, W. H. (1980) · PubMed · Cited by 143 · see citing works
ACTIONS AND USES OF DINITROPHENOL
Cutting, W., MEHRTENS, H. G., & Tainter, M. L. (1933) · JAMA · doi:10.1001/jama.1933.02740280013006 · Cited by 138 · see citing works
Brinkley, J. R. (1930) · JAMA · doi:10.1001/jama.1930.02710440064029 · Cited by 123 · see citing works
Young, J. H. (2015) · Princeton University Press eBooks · doi:10.1515/9781400869008 · Cited by 123 · see citing works
USE OF DINITROPHENOL IN OBESITY AND RELATED CONDITIONS: A PROGRESS REPORT
TAINTER, M. L., STOCKTON, A. B., & CUTTING, W. C. (1933) · Journal of the American Medical Association · doi:10.1001/jama.1933.02740440032009 · Cited by 112 · see citing works
The history and contemporary challenges of the US Food and Drug Administration
Borchers, A. T., Hagie, F., Keen, C. L., & Gershwin, M. E. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.01.006 · Cited by 92 · see citing works
Use of Dinitrophenol in Nutritional Disorders: A Critical Survey of Clinical Results
Tainter, M. L., Cutting, W. C., & Stockton, A. B. (1934) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.24.10.1045 · Cited by 90 · see citing works
Protecting America's Health: The FDA, Business, and One Hundred Years of Regulation
Charatan, F. B. (2004) · BMJ · doi:10.1136/bmj.328.7447.1080 · Cited by 62 · see citing works
Food and Drug Legislation in the New Deal
Garber, M. W., & Jackson, C. O. (1971) · The American Historical Review · doi:10.2307/1869895 · Cited by 54 · see citing works
Regulation of Drugs and Devices: An Evolution
Merrill, R. A. (1994) · Health Affairs · doi:10.1377/hlthaff.13.3.47 · Cited by 50 · see citing works
The Food, Drug, and Cosmetic Act of 1938: Its Legislative History and Its Substantive Provisions
Cavers, D. F. (1939) · Law and Contemporary Problems · doi:10.2307/1189727 · Cited by 47 · see citing works
CATARACTS FOLLOWING THE USE OF DINITROPHENOL
Horner, W. D. (1935) · JAMA · doi:10.1001/jama.1935.02760280020008 · Cited by 44 · see citing works
SUDDEN DEATH FROM DINITROPHENOL POISONING
Poole, F. E., & Haining, R. B. (1934) · JAMA · doi:10.1001/jama.1934.02750140027011 · Cited by 41 · see citing works
DINITROPHENOL AND ITS RELATION TO FORMATION OF CATARACT
Horner, W. D. (1942) · Archives of Ophthalmology · doi:10.1001/archopht.1942.00880060073002 · Cited by 37 · see citing works
RAPIDLY DEVELOPING CATARACT AFTER DINITROPHENOL
Boardman, W. W. (1935) · JAMA · doi:10.1001/jama.1935.02760280020007 · Cited by 34 · see citing works
Young, J. H. (1962) · The American Journal of the Medical Sciences · doi:10.1097/00000441-196205000-00045 · Cited by 32 · see citing works
A CASE OF FATAL DINITROPHENOL POISONING
Tainter, M. L. (1934) · JAMA · doi:10.1001/jama.1934.02750140033012 · Cited by 31 · see citing works
Healthy Public Relations: The FDA's 1930s Legislative Campaign
Kay, G. (2001) · Bulletin of the history of medicine · doi:10.1353/bhm.2001.0126 · Cited by 28 · see citing works
LATE DEVELOPMENT OF CATARACT FOLLOWING USE OF DINITROPHENOL ABOUT A YEAR BEFORE
Allen, T. D. (1935) · JAMA · doi:10.1001/jama.1935.92760360003009c · Cited by 22 · see citing works
FUNCTIONAL CHANGES IN LIVER, HEART AND MUSCLES, AND LOSS OF DEXTROSE TOLERANCE
MacBRYDE, C. M. (1935) · JAMA · doi:10.1001/jama.1935.02760270015006 · Cited by 21 · see citing works
CATARACT FOLLOWING THE USE OF DINITROPHENOL
Lazar, N. K. (1935) · JAMA · doi:10.1001/jama.1935.92760360002009a · Cited by 18 · see citing works
DINITROPHENOL POISONING CAUSING JAUNDICE: REPORT OF CASE
Sidel, N. (1934) · JAMA · doi:10.1001/jama.1934.72750300002011a · Cited by 17 · see citing works
CATARACTS FOLLOWING DINITROPHENOL
Kniskern, P. W. (1935) · JAMA · doi:10.1001/jama.1935.92760360002009b · Cited by 14 · see citing works
Cogan, D. G. (1935) · JAMA · doi:10.1001/jama.1935.92760360001009 · Cited by 11 · see citing works
Council on Pharmacy and chemistry
(1935) · JAMA · doi:10.1001/jama.1935.02760270033012 · Cited by 9 · see citing works
ACUTE COMPLETE GRANULOPENIA WITH DEATH DUE TO DINITROPHENOL POISONING
GOLDMAN, A. (1936) · JAMA · doi:10.1001/jama.1936.02770520017005 · Cited by 7 · see citing works
Cogan, D. G., & Cogan, F. C. (1935) · New England Journal of Medicine · doi:10.1056/nejm193510312131804 · Cited by 6 · see citing works
Shutes, M. H. (1935) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(35)91515-x · Cited by 6 · see citing works
The Administration of the Federal Food and Drugs Act
Hayes, L. T., & Ruff, F. J. (1933) · Law and Contemporary Problems · doi:10.2307/1189448 · Cited by 4 · see citing works
Atlas of Diseases of the Anterior Segment of the Eye.
(1966) · Annals of Internal Medicine · doi:10.7326/0003-4819-65-4-874_3 · Cited by 3 · see citing works
(1936) · JAMA · doi:10.1001/jama.1936.02770180061024 · Cited by 1 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Mitochondrial Uncoupling: A Key Controller of Biological Processes in Physiology and Diseases
Demine, S., Renard, P., & Arnould, T. (2019) · Cells · doi:10.3390/cells8080795 · Cited by 476 · see citing works
“The reported side effects of DNP include acute cataract [261,262], sensory axonal polyneuropathy [263], fever, tachycardia, sweating, nausea, rash, breathing difficulties, abdominal pain, agitation, headache, and death [264,265].”
BackgroundHermetet, C., Jourdan, M., Baert, A., Gheddar, L., Ameline, A., Kintz, P., & Bouvet, R. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1452196 · Cited by 5 · see citing works
I Can Get Fat Where? The Other Types of Fat
Denton, N. (2021) · Oxford University Press eBooks · doi:10.1093/med/9780198865278.003.0004
- Authors
- Margo, C. E., & Harman, L. E.
- Affiliations
- University of South Florida (US)
- Corresponding author
- Margo, Curtis E.
- ORCID
- Margo, Curtis E.
- Venue
- Survey of Ophthalmology
- Publisher
- Elsevier BV
- Published
- 2014-09
- Volume
- 59
- Issue
- 5
- Pages
- 568-573
- ISSN
- 0039-6257 (ISSN-L)
- OpenAlex
- W2123472989
- Cited by
- 3
- References
- 38
- Citations by year
- 2024: 1 · 2021: 1 · 2019: 1
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Survey of Ophthalmology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Health Professions › Health Information Management › Healthcare Regulation
- Social Sciences › Arts and Humanities › History and Philosophy of Science › History of Science and Medicine
- Health Sciences › Medicine › Ophthalmology › Drug-Induced Ocular Toxicity
- Keywords
- dinitrophenol, weight loss pills, Food and Drug Administration, consumer protection law, New Deal, ocular toxicity, cosmetic regulation, public health campaigns, congressional lobbying
- MeSH terms
- Cataract, Consumer Product Safety, Diet, Dinitrophenols, Disease Outbreaks, Humans, Legislation, Drug, United States, United States Food and Drug Administration, Anti-Obesity Agents, History, 20th Century
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review